Jason A. Keyes - 23 Jan 2025 Form 4 Insider Report for Equillium, Inc. (EQ)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
24 Jan 2025, 18:37:21 UTC
Prior SEC filing
06 Jan 2025
Next SEC filing
19 Feb 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jason A. Keyes

Key filing fact

Jason A. Keyes filed Form 4 for Equillium, Inc. (EQ) on 24 Jan 2025.

Key facts

  • This page summarizes Jason A. Keyes's Form 4 filing for Equillium, Inc. (EQ).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 24 Jan 2025, 18:37.

Change

  • Previous filing in this sequence was filed on 06 Jan 2025.
  • Current net transaction value: -$6,500.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EQ transaction

Common Stock

Sale

Transaction value
$6,500
Shares
-10,000
Change %
-21%
Price
$0.6500
Shares after
37,720
Date
23 Jan 2025
Ownership
By The Keyes Trust Dated September 10, 2004
Footnotes
F1, F2
EQ holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
88,913
Date
23 Jan 2025
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2024.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.62 to $0.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .